The FDA has approved vardenafil (LevitraBayer and GlaxoSmithKline) for the treatment of erectile dysfunction in men. Vardenafil joins sildenafil (Viagra) as the only 2 drugs approved for this indication in this country.
Weekly injections of alpha-hydroxyprogesterone caproate resulted in a substantial reduction in the rate of recurrent preterm delivery among women who were at particularly high risk for preterm delivery and reduced the likelihood of several complications in their infants.
The Womens Health Initiative (WHI) reports that estrogen-progestin therapy reduces fractures, but the number of gynecologic cancers observed precludes a definitive statement on the risk of endometrial and ovarian cancers.
As pointed out in previous OB/GYN Clinical Alerts, about 1 in 4 patients in the United States are delivered by cesarean section, a procedure still classified as a major operation.
A generic form of paroxetine (PaxilGlaxoSmithKline) will soon be on the market. The drug marks the second SSRI antidepressant to go generic after fluoxetine (Prozac) last year.
People are either equol producers or nonequol producers, and the clinical benefits of soy isoflavones may be limited to equol producers.
An electrosurgical bipolar vessel sealer reduces the operating time and blood loss in a series of vaginal hysterectomies.
Early experience with fetal MMC repair suggests a decreased need for ventriculoperitoneal shunting, arrest, or slowing of progressive ventriculomegaly, and consistent resolution of hindbrain herniation.
Menstrual irregularities are arguably the mainstay of gynecologic office practice. The differential diagnosis for this common presentation is quite extensive, but a common cause is reduced central hypothalamic GnRH drive due to lifestyle issues.
